1. From the Section on Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
2. Associate Clinical Professor, School of Medicine, Allergy/Immunology, University of California, San Diego School of Medicine, San Diego, California, and
3. AstraZeneca, Drug Development, Wilmington, Delaware